NCT04447781: Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 |
|
|
| Completed | 1/2 | 79 | RoW | INO-4800, CELLECTRA® 2000, Saline-sodium citrate (SSC) buffer, Placebo | International Vaccine Institute, Coalition for Epidemic Preparedness Innovations, Inovio Pharmaceuticals | Coronavirus Infection, SARS-CoV 2 | 07/21 | 05/22 | | |
